• OPEN AN ACCOUNT
Indian Indices
Nifty
24,565.35 -203.00
(-0.82%)
Sensex
80,599.91 -585.67
( -0.72%)
Bank Nifty
55,617.60 -344.35
( -0.62%)
Nifty IT
34,649.60 -652.00
( -1.85%)
Global Indices
Nasdaq
43,604.51 -547.48
(-1.24%)
Dow Jones
6,258.79 -101.60
(1.60%)
Hang Seng
40,837.80 -232.02
(-0.56%)
Nikkei 225
9,068.58 -64.23
(-0.70%)
Forex
USD-INR
87.57 0.14
(0.16%)
EUR-INR
100.09 -0.48
(-0.48%)
GBP-INR
115.87 -0.55
(-0.47%)
JPY-INR
0.58 0.00
(-0.74%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
78.47
390863.66
EPS(TTM)
Face Value()
Div & Yield %
20.76
1
0.98
 

Arigato Universe reports standalone net loss of Rs 0.10 crore in the March 2025 quarter
May 30,2025
Net loss of Arigato Universe reported to Rs 0.10 crore in the quarter ended March 2025 as against net profit of Rs 0.05 crore during the previous quarter ended March 2024. Sales rose 697.73% to Rs 7.02 crore in the quarter ended March 2025 as against Rs 0.88 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 3.31 crore in the year ended March 2025 as against net profit of Rs 0.24 crore during the previous year ended March 2024. Sales rose 318.82% to Rs 7.12 crore in the year ended March 2025 as against Rs 1.70 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales7.020.88 698 7.121.70 319
OPM %-5.13-5.68 --53.51-9.41 -
PBDT-0.100.06 PL -3.300.28 PL
PBT-0.100.06 PL -3.310.28 PL
NP-0.100.05 PL -3.310.24 PL